Banner

Experts elucidate management tips from glaucoma trials

Article

Practitioners need to evaluate risk factors, life expectancy, patient preference

Related Videos
Related Content

Prevent Blindness promoting contact lens safety

October 1st 2023

EyePod: Week in Review - September 24, 2023

September 30th 2023

Novartis finalizes divestment of ‘front of eye’ ophthalmology assets

September 30th 2023

EyePod: Transforming the MIGS pipeline into clinical reality

September 26th 2023

Outlook Therapeutics requests Type A meeting with FDA

September 29th 2023

Humonix Biosciences debuts new 3D human tissue model

September 29th 2023

Prevent Blindness promoting contact lens safety

October 1st 2023

EyePod: Week in Review - September 24, 2023

September 30th 2023

Novartis finalizes divestment of ‘front of eye’ ophthalmology assets

September 30th 2023

EyePod: Transforming the MIGS pipeline into clinical reality

September 26th 2023

Outlook Therapeutics requests Type A meeting with FDA

September 29th 2023

Humonix Biosciences debuts new 3D human tissue model

September 29th 2023

Prevent Blindness promoting contact lens safety

October 1st 2023

EyePod: Week in Review - September 24, 2023

September 30th 2023

Novartis finalizes divestment of ‘front of eye’ ophthalmology assets

September 30th 2023

EyePod: Transforming the MIGS pipeline into clinical reality

September 26th 2023

Outlook Therapeutics requests Type A meeting with FDA

September 29th 2023

Humonix Biosciences debuts new 3D human tissue model

September 29th 2023
© 2023 MJH Life Sciences

All rights reserved.